Virus Diseases

377 trials 110 recruiting

Filter these 377 trials by phase, country and sponsor.

Open in Search →

Clinical trial of colchicine to reduce coronary artery inflammation in people with HIV. Pending

2024-520346-39-00 High cardiovascular risk in HIV patients 4
Vaccination against respiratory syncytial virus in patients with inflammatory rheumatic diseases. The impact of anti-rheumatic treatments on… Pending

2024-518191-31-00 Inflammatory rheumatic disease 6
Safety and efficacy of steering of immunosuppression based on BKPyV-specific T cells in case of BK Polyomavirus (BKPyV) DNAemia after kidney… Pending

2024-517219-56-00 BK Polyomavirus DNAemia after kidney transplantation 6
The RAPID-Elapse study: Can the drug bupropion improve fatigue symptoms in patients with long COVID? Pending

2025-524443-12-00 Post Covid Syndrome (PCS) 4
A multicenter, open-label, dose-escalation clinical trial to evaluate the safety of viral-specific T-cell (VST) therapy in the treatment of … Pending

2024-517696-21-01 Resistant viral infections caused by cytomegalovirus (C 1
TARGET-EBV in MS: Targeting Epstein Barr Virus with Tenofovir Alafenamide Fumarate in multiple sclerosis Pending

2025-522140-40-00 multiple sclerosis 4
The DELTA-EBV study Pending

2025-522781-77-01 Epstein-Barr virus infection 4
Vitamin D as add-on treatment option of pneumonia and sepsis in elderly subjects (TreatViD) Pending

2024-515978-27-00 Sepsis 11
The papillon study Pending

2024-520419-42-00 giving a commercially available vaccine to women with H 11
Application of radiomics for diagnosis and follow-up of cardiovascular device infections: PREDICT study Pending

2025-524624-21-00 Cardiovascular device infections 6
Cysteamine in association with standard therapy for the treatment of hospitalized patients with COVID-19 pneumonia: phase 2 study on safety … Pending

2024-516800-40-00 Infectious diseases of respiratory system (COVID-19) 4
Immune response to intradermally administered Ixiaro in healthy adults Pending

2024-519876-17-00 18-64 years old volunteers with general good health 6
Randomized Multicentric Proof-of-Concept Phase 2 Trial Doravirine in the Early Outpatient Management of West Nile Virus Infection in Patien… Pending

2025-521677-14-00 West Nile Virus Infection 4
A Phase 1, placebo-controlled, randomized, participant- and assessor-blind, single-center study to assess the safety and immunogenicity of 2… Pending

2025-522293-37-00 Nipah Virus 1
A multicentre, open-label trial in healthy volunteers to assess the boostability of three different rabies pre-exposure prophylaxis regimens… Pending

2025-524765-24-00 Rabies infection/prophylaxis 5
EarLy extra Measles immunisation during a measles Outbreak (ELMO) Pending

2024-513395-18-00 Healthy infants receiving a profylactic vaccine to prev 6
Phase IV study to evaluate the safety and efficacy of maribavir in reducing Epstein–Barr virus in young adult kidney transplant recipients. Pending

2025-524786-25-00 Transplant patients with high recurrent Epstein-Barr in 6
Durability of Immunity induced by the Ebolavirus Vaccine VSV-EBOV and Assessment of a Booster Dose for Pre-Exposure Prophylaxis in Individua… Pending

2024-517352-35-00 Ebola virus infection 10
Treatment of Respiratory Complications Associated with COVID-19, Influenza A, Metapneumovirus, Respiratory Syncytial Virus (RSV) Infection U… Pending

2024-519391-11-00 Respiratory viral disease 3
Locating microclots with PET in post-COVID syndrome Pending

2025-522348-42-00 post-COVID syndrome (long COVID) 9
Post-INFECT: Investigating Neuroinflammation and its effects in post-COVID syndrome Pending

2025-522349-23-00 post-COVID syndrome 5
Enhancing infant mucosal immunity through vaccination during lactation. Pending

2025-524862-12-00 Measles 6
Phase 1 (sequential)/2a (parallel), double-blind, multicenter, randomized, controlled study to evaluate the safety and immunogenicity of two… Pending

2024-517396-20-00 Sarbecoviruses disease 9
A Phase 1, Double-blind, Randomized, Placebo-controlled, First-in-Human Study of Orally Administered DF-006 to Evaluate the Safety, Tolerabi… Pending

2023-504288-18-00 Chronic Hepatitis B 3